General Archive

-
ArticlesAisling Burnand CBE, 1964-2022
It is with deep sadness that we share the news that Aisling Burnand CBE passed away on Monday 19 September…
-
ArticlesSeparate science from politics: save the UK’s science sector
LifeArc’s Chief Scientific Officer calls for UK science to continue to be a contributor to the Horizon Europe programme.
-
ArticlesSeven questions about LifeArc’s 2030 ambitions
Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.
-
ArticlesAdvancing novel gene therapies into the clinic
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
-
ArticlesStudy reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
-
ArticlesStartup wins first Advise & Connect Innovation Award
iLOF is a startup that has a novel technology with the potential to transform personalised medicine.
-
ArticlesMilner Therapeutics Institute and LifeArc extend strategic partnership
Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics
-
ArticlesAccelerating progress against dementia
How can we reduce the impact of dementia on individuals, families and wider society?
-
ArticlesLearning from translational research success stories during the COVID-19 pandemic
Melanie Lee on how bringing together diverse teams united under a clear purpose can deliver extraordinary results.
-
ArticlesHackathon brings scientists together to tackle brain health
Together with the patient charity Motor Neurone Disease (MND) Association, LifeArc co-sponsored an MND challenge within a four-day ‘hackathon’ event,…
-
ArticlesCovid-19 hub shortlisted for Scottish award
Unique translational research hub for Covid-19 and other viruses was a finalist in the Scottish Knowledge Exchange Awards.
-
ArticlesLiving with genetic sight loss – a family story
Late-onset retinal degeneration (L-ORD) is a rare inherited eye disease that leads to blindness in older people.
